补充营养援助计划和对抗高血压药物的坚持
Md Mohaimenul Islam1, Ximena Oyarzun-Gonzalez1, Seuli Bose-Brill2
1Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, Columbus.
JAMA network open
|February 23, 2024
概括
补充营养援助计划 (SNAP) 可以减少对血压药物的不坚持,特别是在那些面临粮食不安全的人群中. 这一发现突显了SNAP.
科学领域:
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
- 营养干预 营养干预
背景情况:
- 不坚持服用抗高血压药物会导致血压失控,死亡率增加,医疗费用增加.
- 粮食不安全是一个重要的,可修改的风险因素,导致药物不服药.
- 补充营养援助计划 (SNAP) 是一项旨在缓解粮食不安全的社会干预.
研究的目的:
- 为了确定SNAP福利收到是否会改变粮食不安全对抗高血压药物不服药的影响.
- 为了调查SNAP参与与服用降血压药物之间的关联.
主要方法:
- 使用链接的医疗支出小组调查 (MEPS) -国家卫生访谈调查 (NHIS) 数据 (2016-2017) 的回顾性队列研究.
- 评估了抗高血压药物补充坚持 (MRA < 80%) 和粮食不安全状态.
- 使用治疗逆概率 (IPT) 权重和分层分析来评估SNAP的影响,特别是在粮食不安全的个体中.
主要成果:
- 在6,692名参与者中,SNAP接收与一般人群中不遵守SNAP无关.
- 然而,SNAP的好处与粮食不安全的个体中不遵守政策的显著减少13.6个百分点有关.
- 在食品安全小组中,没有观察到SNAP与遵守之间的显著关联.
结论:
- 参与SNAP可能会改善对抗高血压药物的坚持,特别是对于经历粮食不安全的人来说.
- 研究结果表明,SNAP可以作为一种有价值的干预措施,以提高弱势群体的药物坚持.
- 建议进行进一步的前性研究,以确认SNAP在预防药物不服药方面的作用.
相关概念视频
01:25Antihypertensive Drugs: Direct Renin Inhibitors
629
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
629
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
01:18Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
638
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
638
01:28Drug Therapy
44
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
44
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
731
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
731